... which could face generic competition from April and Seroquel, for schizophrenia and bipolar disorder, which may face a generic rival from late March. ...
... the stomach acid treatment Nexium and the schizophrenia drug Seroquel, are set to plunge amid growing competition from manufacturers of generic drugs. ...
As a worst-case scenario, it highlighted the group''s key Nexium and Seroquel products as potential ''at risk'' launches, while it noted that the current ...
... note published this morning, the analysts mention that the company faces the risk of the launch of generics for its two key drugs, Nexium and Seroquel. ...
L: Quote, Profile, Research) is trying to head off the threat of generic competition to its blockbuster schizophrenia drug Seroquel by seeking a summary ...
Meanwhile the broker remains a buyer Dawnay, Day Treveria, but cuts its target price on Rolls-Royce to 400p a share while maintaining the hold ...
Meantime, AstraZeneca has submitted applications in the European Union for a once-daily extended-release version of Seroquel (quetiapine fumarate). ...
Teva is challenging the patents protecting Seroquel and could launch a cheap generic copy of the medicine in the United States as early as the end of March, ...
L: Quote, Profile, Research) said on Monday it had filed Seroquel XR, an extended-release version of the original medicine designed for once-daily use, ...
all 8 news articles